73 results
424B5
PCSA
Processa Pharmaceuticals Inc
28 May 24
Prospectus supplement for primary offering
4:49pm
and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy oncology drug products. Our mission is to provide better treatment options … and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy oncology drug products. Our mission is to provide better treatment
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy (“NGC”) oncology drug products. Our mission is to provide better … mission. We continue to be focused on drug products that improve the survival and/or quality of life for patients by improving the safety and/or efficacy
8-K
EX-99.1
4zx90o8 z90
31 Mar 23
Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
8:30am
8-K
EX-99.1
0d8e4eb2esbg
14 Dec 22
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
11:22am
8-K
EX-99.1
9yknza9f2rgvn ktj80
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.2
28ig9pyz
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
45ri3 97ji
4 Nov 22
Other Events
11:24am
8-K
EX-99.1
3qudba4vthp
12 Aug 22
Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
10:35am
8-K
EX-99.1
5d4l1d 0xyh
4 Aug 22
Regulation FD Disclosure
9:30am